NCT01915277View on ClinicalTrials.gov

A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics

PHASE1CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 2, 2014

Primary Completion Date

October 16, 2017

Study Completion Date

October 17, 2017

Conditions
Transposition of the Great ArteriesTetralogy of FallotVentricular Septal Defect
Interventions
DRUG

Dexmedetomidine

Trial Locations (4)

19104

Childrens Hospital of Philadelphia, Philadelphia

48109

University of Michigan, Ann Arbor

77030

Texas Children's Hospital, Houston

02111

Boston Children's Hospital, Boston

Sponsors

Lead Sponsor

Carelon Research
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Carelon Research

OTHER